
UK speciality pharma group Clinigen is paying £225 million to acquire the Surrey-based unlicensed supplier of medicines firm Idis. Unlicensed …

Former Quintiles president Jeff Thomis has been appointed to the role of chairman at Idis. In his new role, Thomis …
With increasing requests from healthcare professionals and patients globally for access to drugs that are still in clinical development or …
Richard Greatorex has joined specialist medicines supplies company Idis as international marketing manager for its global headquarters in the UK. …
Specialist medicines supplies company IDIS has hired a leading PR agency to help promote its business across Europe. Ogilvy Healthworld …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

